NCT03945968 The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
| NCT ID | NCT03945968 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Russian Federation of Anesthesiologists and Reanimatologists |
| Condition | Coronary Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 16,000 participants |
| Start Date | 2019-07-01 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 16,000 participants in total. It began in 2019-07-01 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study is conducted to assess the prevalence and structure of comorbidity among patients undergoing abdominal surgery and produce the stratification of the risk of postoperative complications by identifying independent predictors for its development.
Eligibility Criteria
Inclusion Criteria: * surgical interventions on the abdominal organs, * 1-3 ASA physical status class Exclusion Criteria: * the inability to assess the factors included in the study, * acute massive blood loss, aspiration, * bronchospasm, * anaphylactic reactions, * malignant hyperthermia
Contact & Investigator
Igor Zabolotskikh, MD
PRINCIPAL INVESTIGATOR
Russian Federation of Anesthesiologists and Reanimatologists
Frequently Asked Questions
Who can join the NCT03945968 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03945968 currently recruiting?
Yes, NCT03945968 is actively recruiting participants. Contact the research team at nikitkax@mail.ru for enrollment information.
Where is the NCT03945968 trial being conducted?
This trial is being conducted at Arkhangelsk, Russia, Astrakhan, Russia, Chelyabinsk, Russia, Chelyabinsk, Russia and 11 additional locations.
Who is sponsoring the NCT03945968 clinical trial?
NCT03945968 is sponsored by Russian Federation of Anesthesiologists and Reanimatologists. The principal investigator is Igor Zabolotskikh, MD at Russian Federation of Anesthesiologists and Reanimatologists. The trial plans to enroll 16,000 participants.